There are 2949 resources available
Exploring molecular heterogeneity in prostate cancer - prevalence and clinical significance
Presenter: Neal Shore
Session: AstraZeneca - PARP inhibitors in the treatment of metastatic castrate resistant prostate cancer
Resources:
Webcast
Welcome and introduction
Presenter: Pasi Jänne
Session: Daiichi Sankyo -Antibody Drug Conjugates (ADCs): Advancements in the treatment of solid tumours
Resources:
Webcast
ADCs as a technologically advanced treatment approach in solid tumours
Presenter: Pasi Jänne
Session: Daiichi Sankyo -Antibody Drug Conjugates (ADCs): Advancements in the treatment of solid tumours
Resources:
Webcast
Current clinical experience with innovative ADCs in breast cancer
Presenter: Javier Cortés
Session: Daiichi Sankyo -Antibody Drug Conjugates (ADCs): Advancements in the treatment of solid tumours
Resources:
Webcast
Latest findings from clinical trials in lung cancer with technologically advanced ADCs
Presenter: Pasi Jänne
Session: Daiichi Sankyo -Antibody Drug Conjugates (ADCs): Advancements in the treatment of solid tumours
Resources:
Webcast
Recent clinical findings with novel ADCs in colorectal and gastric cancer
Presenter: Kanwal Raghav
Session: Daiichi Sankyo -Antibody Drug Conjugates (ADCs): Advancements in the treatment of solid tumours
Resources:
Webcast
Summary and close
Presenter: Pasi Jänne
Session: Daiichi Sankyo -Antibody Drug Conjugates (ADCs): Advancements in the treatment of solid tumours
Resources:
Webcast
From breast cancer to other tumors: Lessons learned from targeting the HER pathway
Presenter: Javier Cortés
Session: Medscape - The HER-pathway in advanced solid tumours: Advances in targeting HER2 and future prospects for HER3
Resources:
Webcast
Defining HER2 and HER3 status: Taking a deeper dive
Presenter: Giuseppe Viale
Session: Medscape - The HER-pathway in advanced solid tumours: Advances in targeting HER2 and future prospects for HER3
Resources:
Webcast
Recent developments for the patient with HER2-positive metastatic breast cancer
Presenter: Sara Hurvitz
Session: Medscape - The HER-pathway in advanced solid tumours: Advances in targeting HER2 and future prospects for HER3
Resources:
Webcast